{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 9,
        "Specificity": 8,
        "Sector_Spread": 7,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "JNJPharm15 announces a breakthrough in HCV treatment, potentially disrupting the market dominated by GILD and ABBV. This could lead to increased competition and pressure on current leaders.",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 9,
            "Specificity": 9,
            "Sector_Spread": 8,
            "Tech_Mentions": 2
        },
        {
            "News_content": "JNJ reports strong Q3 earnings, beating analyst expectations. The stock is expected to see an upward trend in the short term.",
            "Correlation": 8,
            "Sentiment": 8,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 4,
            "Source_Score": 9,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "HCV treatments are gaining more attention as new research shows promising results. This could benefit companies like JNJ, GILD, and ABBV.",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "GILD's stock price drops after a key analyst downgrades the stock citing competitive pressures from JNJ and ABBV.",
            "Correlation": 8,
            "Sentiment": 4,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 9,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "ABBV is rumored to be considering a strategic acquisition in the HCV space to counteract JNJ's recent advances.",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 6,
            "Virality": 3,
            "Source_Score": 8,
            "Specificity": 7,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "ACHN shares surge after announcing a potential partnership with JNJ for HCV drug development.",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 7,
            "Impact": 7,
            "Duration": 5,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        }
    ]
}